EAM
EXAS

Eventide Asset Management’s Exact Sciences EXAS Stock Holding History

Eventide Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-254,921
Closed -$25.9M – 287
2025
Q4 		$25.9M Sell
254,921
-310,653
-55% -$24.9M 0.4% 89
2025
Q3 		$30.9M Buy
565,574
+28
+0% +$1.4K 0.51% 75
2025
Q2 		$30.1M Hold
565,546
– – 0.53% 70
2025
Q1 		$24.5M Sell
565,546
-667,838
-54% -$33.8M 0.49% 75
2024
Q4 		$69.3M Buy
1,233,384
+1,265
+0.1% +$78.7K 1.26% 24
2024
Q3 		$83.9M Buy
1,232,119
+391
+0% +$22.1K 1.45% 18
2024
Q2 		$52M Buy
1,231,728
+147,006
+14% +$8.09M 0.89% 36
2024
Q1 		$74.9M Buy
1,084,722
+1,409
+0.1% +$89.1K 1.17% 30
2023
Q4 		$80.1M Sell
1,083,313
-784,737
-42% -$51.4M 1.31% 26
2023
Q3 		$127M Buy
1,868,050
+336
+0% +$28.5K 2.29% 6
2023
Q2 		$175M Buy
1,867,714
+178
+0% +$13.9K 2.96% 3
2023
Q1 		$127M Buy
1,867,536
+171
+0% +$11K 2.32% 8
2022
Q4 		$92.5M Hold
1,867,365
– – 1.82% 18
2022
Q3 		$60.7M Buy
1,867,365
+501,765
+37% +$20.7M 1.19% 28
2022
Q2 		$53.8M Sell
1,365,600
-124,400
-8% -$6.65M 1.15% 32
2022
Q1 		$104M Hold
1,490,000
– – 1.63% 23
2021
Q4 		$116M Hold
1,490,000
– – 1.48% 27
2021
Q3 		$142M Sell
1,490,000
-250,000
-14% -$26.4M 1.88% 10
2021
Q2 		$216M Hold
1,740,000
– – 2.91% 4
2021
Q1 		$229M Hold
1,740,000
– – 3.4% 1
2020
Q4 		$231M Hold
1,740,000
– – 3.54% 2
2020
Q3 		$177M Hold
1,740,000
– – 3.47% 2
2020
Q2 		$151M Buy
1,740,000
+348,000
+25% +$27.8M 3.29% 3
2020
Q1 		$80.7M Buy
1,392,000
+897,000
+181% +$72.8M 2.61% 4
2019
Q4 		$45.8M Hold
495,000
– – 1.29% 29
2019
Q3 		$44.7M Hold
495,000
– – 1.48% 23
2019
Q2 		$58.4M Buy
495,000
+355,000
+254% +$35.8M 1.78% 12
2019
Q1 		$12.1M Buy
140,000
+9,000
+7% +$766K 0.42% 71
2018
Q4 		$8.27M Hold
131,000
– – 0.37% 74
2018
Q3 		$10.3M Hold
131,000
– – 0.38% 76
2018
Q2 		$7.83M Hold
131,000
– – 0.33% 80
2018
Q1 		$5.28M Buy
131,000
+31,000
+31% +$1.51M 0.25% 89
2017
Q4 		$5.25M Hold
100,000
– – 0.27% 82
2017
Q3 		$4.71M Hold
100,000
– – 0.27% 77
2017
Q2 		$3.54M Buy
+100,000
New +$3.09M 0.22% 86

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Eventide Asset Management's EXAS Position: Q1 2026 in Review

Eventide Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 254,921 shares — an estimated $25.9M sold.

Eventide Asset Management first reported a position in EXAS in Q2 2017 and held it in 35 quarters. The position peaked at $231M in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Eventide Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Eventide Asset Management sold 254,921 Exact Sciences shares in Q1 2026, an estimated $25.9M.
  • Eventide Asset Management first reported a position in Exact Sciences in Q2 2017 and held it in 35 quarters.
  • Eventide Asset Management's Exact Sciences position peaked at $231M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.